Delivery Order SPE2DB22D3016-SPE2DB25FAKU3
Award Date
1/21/25
Potential Completion Date
2/11/25
Potential Value
$46K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors in the world, is for the delivery of CABOMETYX 20 MG TABLET 30S to the Defense Logistics Agency (DLA). The $14,035.64 firm fixed-price delivery order has an ultimate completion date of August 1, 2024. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,346.55 firm fixed-price delivery order is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $56,142.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CABOMETYX 20 MG TABLET 30S, a pharmaceutical product. The contract has a performance period through July 30, 2024 and is a firm-fixed price delivery order. This contract is not associated with any set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,777.92 fixed-price delivery order is for CABOMETYX 60 MG TABLET 30S, a specialty medication, with a period of performance through December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,346.55 firm fixed-price delivery order contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,039.32 Firm Fixed Price Delivery Order is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a period of performance running through December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $15,301.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,301.05 firm fixed-price delivery order is for the supply of CABOMETYX 60 MG TABLET 30S, a medication used in the treatment of certain types of cancer. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, identified as SPE2DB22D3016|SPE2DB25FAQT4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $30,693.10 firm-fixed-price delivery order is for the supply of CABOMETYX 40 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,301.05 contract is for the delivery of CABOMETYX 60 MG TABLET 30S, a medical product used in federal healthcare programs. The contract has an ultimate completion date of February 25, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...